Tectonic Therapeutic Inc has a consensus price target of $80.5 based on the ratings of 5 analysts. The high is $112 issued by Wells Fargo on January 31, 2025. The low is $65 issued by Raymond James on November 20, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Raymond James, and Wells Fargo on January 31, 2025, November 20, 2024, and November 12, 2024, respectively. With an average price target of $85.33 between Wells Fargo, Raymond James, and Wells Fargo, there's an implied 85.23% upside for Tectonic Therapeutic Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Tectonic Therapeutic (NASDAQ:TECX) was reported by Wells Fargo on January 31, 2025. The analyst firm set a price target for $112.00 expecting TECX to rise to within 12 months (a possible 143.11% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Tectonic Therapeutic (NASDAQ:TECX) was provided by Wells Fargo, and Tectonic Therapeutic maintained their overweight rating.
There is no last upgrade for Tectonic Therapeutic
There is no last downgrade for Tectonic Therapeutic.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tectonic Therapeutic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tectonic Therapeutic was filed on January 31, 2025 so you should expect the next rating to be made available sometime around January 31, 2026.
While ratings are subjective and will change, the latest Tectonic Therapeutic (TECX) rating was a maintained with a price target of $79.00 to $112.00. The current price Tectonic Therapeutic (TECX) is trading at is $46.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.